Help
RSS
API
Feed
Maltego
Contact
Domain > drkaanaydos.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2025-10-21
23.88.0.101
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyConnection: Keep-AliveKeep-Alive: timeout5, max100Content-Type: text/htmlContent-Length: 795Date: Tue, 21 Oct 2025 15:11:09 GMTServer: LiteSpeedLocation: https://drkaanaydos.com/Vary: User-Agent !DOCTYPE html>html styleheight:100%>head>meta nameviewport contentwidthdevice-width, initial-scale1, shrink-to-fitno />title> 301 Moved Permanently/title>style>@media (prefers-color-scheme:dark){body{background-color:#000!important}}/style>/head>body stylecolor: #444; margin:0;font: normal 14px/20px Arial, Helvetica, sans-serif; height:100%; background-color: #fff;>div styleheight:auto; min-height:100%; > div styletext-align: center; width:800px; margin-left: -400px; position:absolute; top: 30%; left:50%;> h1 stylemargin:0; font-size:150px; line-height:150px; font-weight:bold;>301/h1>h2 stylemargin-top:20px;font-size: 30px;>Moved Permanently/h2>p>The document has been permanently moved./p>/div>/div>/body>/html>
Port 443
HTTP/1.1 200 OKConnection: Keep-AliveKeep-Alive: timeout5, max100Content-Type: text/html; charsetUTF-8Transfer-Encoding: chunkedDate: Tue, 21 Oct 2025 15:11:10 GMTServer: LiteSpeedVary: User-Agent !DOCTYPE html>html classhtml>head> meta charsetutf-8> meta http-equivX-UA-Compatible contentIEedge> meta nameviewport contentwidthdevice-width, initial-scale1> title>Prof.Dr. Kaan Aydos | drkaanaydos.com/title> meta nameauthor contentagency | bossgrey.com> meta namedescription contentMMIC MULTIDISCIPLINARY MALE INFERTILITY CARE Research, Training, Diagnosis, Treatment, Surgery - Prof. Dr. Kaan Aydos Ankara Türkiye> meta namekeywords contentMMIC MULTIDISCIPLINARY MALE INFERTILITY CARE Research, Training, Diagnosis, Treatment, Surgery, Doktor, Azoospermia, Azospermia, micro TESE, male infertility, Kaan Aydos, kaan, aydos, prof, dr, ankara, üroloji, taş, böbrek, prostat, cinsellik, sağlık, yaş> meta namemsapplication-tap-highlight contentno> meta namegoogle valuenotranslate > meta namerobots contentindex,follow> meta namemobile-web-app-capable contentyes> meta namecopyright content(c) 2018 bossgrey.com /> meta nameapple-mobile-web-app-capable contentyes> meta nametwitter:widgets:theme contentlight> meta propertyog:title contentProf.Dr. Kaan Aydos /> meta propertyog:type contentwebsite /> meta propertyog:url contenthttp://www.drkaanaydos.com/> meta propertyog:image contenthttp://www.drkaanaydos.com/assets/images/profdrkaanaydos.jpg /> meta propertyog:description contentMMIC MULTIDISCIPLINARY MALE INFERTILITY CARE Research, Training, Diagnosis, Treatment, Surgery - Prof. Dr. Kaan Aydos Ankara Türkiye /> meta propertyog:image:type contentimage/jpeg> meta propertyog:image:width content1200> meta propertyog:image:height content630> meta nametwitter:url contenthttp://www.drkaanaydos.com/> meta nametwitter:card contentsummary_large_image> meta nametwitter:site contenthttp://www.drkaanaydos.com/> meta nametwitter:title contentProf.Dr. Kaan Aydos> meta nametwitter:description contentMMIC MULTIDISCIPLINARY MALE INFERTILITY CARE Research, Training, Diagnosis, Treatment, Surgery - Prof. Dr. Kaan Aydos Ankara Türkiye> meta nametwitter:image:src contenthttp://www.drkaanaydos.com/assets/images/profdrkaanaydos.jpg> meta itempropname contentProf.Dr. Kaan Aydos> meta itempropdescription contentMMIC MULTIDISCIPLINARY MALE INFERTILITY CARE Research, Training, Diagnosis, Treatment, Surgery - Prof. Dr. Kaan Aydos Ankara Türkiye> meta itempropimage contenthttp://www.drkaanaydos.com/assets/images/profdrkaanaydos.jpg> link relcanonical hrefhttp://www.drkaanaydos.com/ /> link relshortlink hrefhttp://www.drkaanaydos.com/ /> link relshortcut icon typeimage/png href/assets/images/favicon.png /> link relstylesheet hrefhttps://fonts.googleapis.com/css?familyHeebo:100%7COpen+Sans:300,400,400i,600,700,800> link relstylesheet href/assets/css/plugins.css> link relstylesheet href/assets/css/animate.css> link relstylesheet href/assets/css/alien.min.css>style>.messages {text-align: center; padding-top: 15px; display: none; color: #BF9865; width: 100%;} Heading-wing{position:relative;display:inline-block;text-align:center}.Heading-wing::after,.Heading-wing::before{position:absolute;top:50%;width:64px;height:2px;content:;background-color:#000}.Heading-wing::before{left:0;margin-left:-85px}.Heading-wing::after{right:0;margin-right:-85px} .error .bootstrap-select .dropdown-toggle, .has-error .bootstrap-select .dropdown-toggle{border-color:#b94a48}/style>/head>body> div classloader2> div classlogop>img src/assets/images/preload.png altdrkaanaydos.com>/div> div classloader loader_each>span>/span>/div>/div> !--header start--> header> !-- Start Navigation --> nav idmainNav classnavbar navbar-default navbar-fixed navbar-transparent dark white--outline-- no-background bootsnav> div classcontainer> div classattr-nav> ul> li>a hrefhttp://kaanaydos.com.tr target_blank>img src/assets/images/tr.png width20px altTürkçe>/a>/li> /ul> /div> !-- Start Header Navigation --> div classnavbar-header> button typebutton classnavbar-toggle data-togglecollapse data-target#navbar-menu> i classfa fa-bars>/i> /button> a classnavbar-brand href/> img src/assets/images/logo-white.png classlogo logo-display alt> img src/assets/images/logo.png classlogo logo-scrolled alt stylemargin-top: -1px;> /a> /div> !-- End Header Navigation --> !-- Collect the nav links, forms, and other content for toggling --> div classcollapse navbar-collapse idnavbar-menu> ul classnav navbar-nav navbar-right data-in data-out> li classdropdown> a href# classdropdown-toggle data-toggledropdown stylefont-weight: 700>ABOUT/a> ul classdropdown-menu> li>a href/about-mmic>About MMIC/a>/li> li>a href/about>Prof.Dr. Kaan Aydos/a>/li> li>a href/scientific-publications>Scientific Publications/a>/li> /ul> /li> li> a href/team stylefont-weight: 700>TEAM/a> /li> li> a href/articles stylefont-weight: 700>ARTICLES/a> /li> li classdropdown> a href# classdropdown-toggle data-toggledropdown stylefont-weight: 700>SERVICES & EXPERTISE/a> ul classdropdown-menu> li>a href/diagnostic-procedures-research-facilities>Diagnostic procedures & Research facilities/a>/li> li>a href/treatment-options-practices>Treatment Options & Practices/a>/li> /ul> /li> li classdropdown> a href# classdropdown-toggle data-toggledropdown stylefont-weight: 700>MEDIA/a> ul classdropdown-menu> li>a href/videos>Videos/a>/li> li>a href/news>News/a>/li> li>a href/gallery>Gallery/a>/li> li>a href/press-releases>Press Releases/a>/li> /ul> /li> li styledisplay: none;> a href# stylefont-weight: 700>CASE REPORTS/a> /li> li> a href#contact classpopup-with-form stylefont-weight: 700>CONTACT/a> /li> /ul> /div>!-- /.navbar-collapse --> /div> /nav> !-- End Navigation --> div classclearfix>/div> /header> !--header end-->!--slider start--> div classswiper-container js-FullHeight> div classswiper-wrapper> section classswiper-slide ImageBackground ImageBackground--overlay ImageBackground--overlay--gradient- data-overlay0 data-schemelight data-swiper-autoplay200> div classImageBackground__holder> img src/assets/images/banner/profdr-kaan-aydos-661249.jpg alt> /div> /section> /div> !-- Add Arrows --> div classswiper-control swiper-button-next styledisplay: none;>/div> div classswiper-control swiper-button-prev styledisplay: none;>/div> /div> !--slider end--> section classbg-default u-MarginTop0 u-BoxShadow40 text-white wow fadeIn > div classcontainer> div classrow u-MarginTop50 u-MarginBottom50> div classcol-md-8> h3 classu-MarginTop5 u-MarginBottom10 u-Weight300 text-center--sm>You can reach our doctor and send your questions tobr>b>Prof. Dr. Kaan Aydos/b>/h3> /div> div classcol-md-4 text-right text-left--xs u-MarginTop20 u-sm-MarginTop30> a href#contact classbtn u-Rounded btn-block btn-black popup-with-form>ASK THE DOCTOR/a> /div> /div> /div> /section> div classImageBlock u-FlexCenter u-xs-Block u-xs-PaddingBottom20> div classImageBlock__image col-md-6 col-sm-4> div classImageBackground ImageBackground--overlay u-BoxShadow100 data-overlay0> div classImageBackground__holder> img src/assets/images/bg1.jpg altdrkaanaydos.com/> /div> /div> /div> div classcontainer> div classrow> div classcol-md-5 col-sm-7 wow fadeInLeft> h1 classu-MarginTop0 u-MarginBottom20 u-FontSize40 u-xs-FontSize30 u-LineHeight1 text-font>What are we working for/h1> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Our ever-expanding researches on male factor infertility have demonstrated the need of collaborative efforts of molecular biologists and clinicians to definitively diagnose and treat the male factor infertility cases. Then we redirected our efforts to identify better male fertility biomarkers. We extensively studied detrimental insults of oxidative stress and DNA fragmentation index as male fertility biomarkers. However, not only DNA but also various protein profiles, RNA elements and other molecules in a sperm cell are delivered to the oocyte to achieve a healthy fertilization and pregnancy. Regarding these facts we started to investigate seminal plasma markers from men trying to conceive as the first-line diagnostic criteria, especially in the decision to precede the mikroTESE. Even, only performing microTESE is not enough but deciding what to do when it fails is also required. On the other hand our data revealed the decisive potency of some Sertoli cell markers in either testicular tissue extracts or ejaculate to differentiate subtypes of NOA. Beside routine practices we are extensively dealing with experimental researches to define genomic and other etiologies of infertility with the aid of novel technologies. /p> /div> /div> /div> /div> div classImageBlock ImageBlock--switch u-FlexCenter u-xs-Block u-xs-PaddingBottom20> div classImageBlock__image col-md-6 col-sm-4> div classImageBackground ImageBackground--overlay u-BoxShadow100 data-overlay0> div classImageBackground__holder> img src/assets/images/bg2.jpg altdrkaanaydos.com/> /div> /div> /div> div classcontainer> div classrow> div classcol-md-5 col-sm-7 wow fadeInRight> h1 classu-MarginTop0 u-MarginBottom20 u-FontSize40 u-xs-FontSize30 u-LineHeight1 text-font>Service Policy/h1> p classu-FontSize14 u-LineHeight1-5 u-Weight300>According to our policy, patient privacy is the most important issue. We recommend reliable treatments with proven results, based on both scientific studies and our own experiences, without harming the person. In the planning of the treatment, not to compromise the quality, following the latest innovations, and minimum cost are essential. But above all, to restore the patients morale is our main behavior. /p> p classu-FontSize14 u-LineHeight1-5 u-Weight300>In the infertility treatment extremely exciting researches are done. However, hoping in vain before seeing the results creates frustration. Only realistic expectations maximize patient satisfaction. While presenting new developments to the patients, we consider the fact that the treatment results are based on realistic and substantial data. Special attention is paid to the most reasonable cost balance with high-quality service./p> /div> /div> /div> /div> section classu-BoxShadow100 u-PaddingTop60 u-PaddingBottom60 u-xs-PaddingTop10 u-xs-PaddingBottom30 wow fadeIn> div classtext-center> h2 classHeading-wing stylemargin-bottom: 10px; letter-spacing: 0; margin-bottom: 50px;>ARTICLES/h2> /div> div classcontainer> div classrow> div classcol-md-12> div classjs-Portfolio portfolio-grid grid-3 gutter> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/article/radiotherapy-and-male-infertility>img classimg-responsive src/assets/images/makale/radiotherapy-and-male-infertility-1234.jpg altRADIOTHERAPY AND MALE INFERTILITY>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/article/radiotherapy-and-male-infertility>RADIOTHERAPY AND MALE INFERTILITY/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Radiation therapy, also known as radiotherapy or x-ray therapy, has been an effective treatment method in many cancer types./p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/article/radiotherapy-and-male-infertility rolebutton>READ MOREi classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/article/what-is-male-infertility>img classimg-responsive src/assets/images/makale/what-is-male-infertility-1897.jpg altWHAT IS MALE INFERTILITY?>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/article/what-is-male-infertility>WHAT IS MALE INFERTILITY?/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>After couples intend to have a child, if there is still no pregnancy within 1 year, although they have a regular sexual life and do not use any contraception/p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/article/what-is-male-infertility rolebutton>READ MOREi classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/article/sperm-quality-is-important-in-ivf-icsi-success>img classimg-responsive src/assets/images/makale/sperm-quality-is-important-in-ivf-icsi-success-1101.jpg altSPERM QUALITY IS IMPORTANT IN IVF/ICSI SUCCESS>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/article/sperm-quality-is-important-in-ivf-icsi-success>SPERM QUALITY IS IMPORTANT IN IVF/ICSI SUCCESS/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>IVF has been a great source of hope for couples who cannot have children naturally./p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/article/sperm-quality-is-important-in-ivf-icsi-success rolebutton>READ MOREi classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> /div> /div> /div> /div> /section> section classbg-lighter u-PaddingTop60 u-PaddingBottom60 u-xs-PaddingTop10 u-xs-PaddingBottom30 wow fadeIn> div classtext-center> h2 classHeading-wing stylemargin-bottom: 10px; letter-spacing: 0; margin-bottom: 50px;>VIDEOS/h2> /div> div classcontainer> div classrow> div classcol-md-12> div classjs-Portfolio portfolio-grid grid-3 gutter> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a hrefhttps://www.youtube.com/watch?vHbOF4KFIp8I classpopup-youtube>img classimg-responsive srchttps://i.ytimg.com/vi/HbOF4KFIp8I/maxresdefault.jpg altOxidative Stress; A Serious Cause Of Unexplained Infertility!>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal popup-youtube hrefhttps://www.youtube.com/watch?vHbOF4KFIp8I>Oxidative Stress; A Serious Cause Of Unexplained Infertility!/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>The most problematic cases of infertility are those with unexplained etiology. Approximately 20% of couples are diagnosed with unexplained infertility after a conventional semen analysis. On the other hand oxidative stress is considered to be one of the major causes of male infertility. Oxidative stress is identified sequentially in 4 steps and since each step is related with separate functions of spermatozoa, in the evaluation of unexplained infertility each of these steps should be evaluated by proper tests./p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a hrefhttps://www.youtube.com/watch?vqG_XDAcWtIs classpopup-youtube>img classimg-responsive srchttps://i.ytimg.com/vi/qG_XDAcWtIs/maxresdefault.jpg altMultidimensional Micro TESE>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal popup-youtube hrefhttps://www.youtube.com/watch?vqG_XDAcWtIs>Multidimensional Micro TESE/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>The ideal approach for microTESE should first be to maximize the likelihood of sperm retrieval.And also, in case of no sperm in the intervention, a forward-looking treatment plan should be determined. We call such treatment as the “Multi-dimensional or extended microTESE” model./p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a hrefhttps://www.youtube.com/watch?vBnZtxVwD7dA classpopup-youtube>img classimg-responsive srchttps://i.ytimg.com/vi/BnZtxVwD7dA/maxresdefault.jpg altMolecular Markers In The Management Of Azoospermia>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal popup-youtube hrefhttps://www.youtube.com/watch?vBnZtxVwD7dA>Molecular Markers In The Management Of Azoospermia/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Basically, markers are particular genomic fragments and used to get information about the function of these genes. Since the production and maturation of sperm cells progress under genetic control, identifying such markers helps us to explain the level and degree of the problem associated with impaired spermatogenesis. Our studies identified a number of important markers helping to manage the treatment of azoospermic patients./p> /div> /div> /div> /div> /div> /div> /div> /div> /section> section classu-BoxShadow100 u-PaddingTop60 u-PaddingBottom60 u-xs-PaddingTop10 u-xs-PaddingBottom30 wow fadeIn> div classtext-center> h2 classHeading-wing stylemargin-bottom: 10px; letter-spacing: 0; margin-bottom: 50px;>NEWS/h2> /div> div classcontainer> div classrow> div classcol-md-12> div classjs-Portfolio portfolio-grid grid-3 gutter> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/new/another-chance-for-azoospermic-men-modified-round-spermatid-injection-rosi>img classimg-responsive src/assets/images/haber/another-chance-for-azoospermic-men-modified-round-spermatid-injection-rosi-267937.jpg altANOTHER CHANCE FOR AZOOSPERMİC MEN: Modified Round Spermatid Injection; ROSI>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 u-Weight300 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/new/another-chance-for-azoospermic-men-modified-round-spermatid-injection-rosi>ANOTHER CHANCE FOR AZOOSPERMİC MEN: Modified Round Spermatid Injection; ROSI/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Azoospermia is defined as the absence of spermatozoa in the ejaculate after a detailed assessment of the semen and diagnosed in approximately 15 % of the infertile males. In fact, most of them suffer from having nonobstructive azoospermia (NOA)/p> p classu-MarginTop20>a href/new/un-altra-possibilit-per-la-sterilit-maschile-fecondare-gli-ovociti-con-spermatidi-rotondi-rosi-modificata>img src/assets/images/it.gif altdrkaanaydos.com>/a>/p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/new/another-chance-for-azoospermic-men-modified-round-spermatid-injection-rosi rolebutton>DEVAMI i classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/new/recovery-of-spermatozoa-and-achieved-pregnancy-by-second-tese-in-a-man-with-unsuccessful-first-tese-attempt>img classimg-responsive src/assets/images/haber/recovery-of-spermatozoa-and-achieved-pregnancy-by-second-tese-in-a-man-with-unsuccessful-first-tese-attempt-507612.jpg altRecovery Of Spermatozoa And Achieved Pregnancy By Second Tese In A Man With Unsuccessful First Tese Attempt>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 u-Weight300 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/new/recovery-of-spermatozoa-and-achieved-pregnancy-by-second-tese-in-a-man-with-unsuccessful-first-tese-attempt>Recovery Of Spermatozoa And Achieved Pregnancy By Second Tese In A Man With Unsuccessful First Tese Attempt/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Y.M. was one of our non-obstructive azoospermic patients. During his first TESE attempt in another center no mature sperm cell was found./p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/new/recovery-of-spermatozoa-and-achieved-pregnancy-by-second-tese-in-a-man-with-unsuccessful-first-tese-attempt rolebutton>DEVAMI i classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> div classportfolio-item wow fadeInUp> div classu-BoxShadow100> div classBlurb> a href/new/predicting-sperm-presence-in-testis-flow-cytometric-monitoring-of-post-meiotic-sperm-cells>img classimg-responsive src/assets/images/haber/predicting-sperm-presence-in-testis-flow-cytometric-monitoring-of-post-meiotic-sperm-cells-387679.jpg altPREDICTING SPERM PRESENCE IN TESTIS: Flow cytometric monitoring of post-meiotic sperm cells>/a> div classu-Padding30 text-center> h3 class u-MarginTop0 u-MarginBottom20 u-Weight300 text-font styleline-height: 1.2>a classBlurb__hoverText link-normal href/new/predicting-sperm-presence-in-testis-flow-cytometric-monitoring-of-post-meiotic-sperm-cells>PREDICTING SPERM PRESENCE IN TESTIS: Flow cytometric monitoring of post-meiotic sperm cells/a>/h3> p classu-FontSize14 u-LineHeight1-5 u-Weight300>Researchers in Mikrogen Genetic Diagnostic Laboratory identified some seminal markers as indicators of presence, quantity and developmental stage of the sperm cells in the testis of azoospermic men./p> p classu-MarginTop25 u-MarginBottom0 styledisplay: none;> a classbtn-go text-uppercase small text-muted href/new/predicting-sperm-presence-in-testis-flow-cytometric-monitoring-of-post-meiotic-sperm-cells rolebutton>DEVAMI i classfa fa-long-arrow-right aria-hiddentrue>/i>/a> /p> /div> /div> /div> /div> /div> /div> /div> /div> /section> !--parallax start--> section classImageBackground ImageBackground--overlay v-align-parent u-height500 hidden-xs data-overlay0> div classImageBackground__holder> img src/assets/images/footer.jpg altdrkaanaydos.com> /div> div classcontainer stylepadding-top: 250px; padding-bottom: 250px;> /div> /section> !--parallax end--> !-- Start Footer --> footer> div classfooter-form> div classfooter-form-top> div classcontainer> div classfooter-xs> div classfooter-xs-right text-left text-center--sm wow fadeIn bg-darker u-xs-PaddingBottom30 u-xs-PaddingTop10 stylebackground: #2D2D32;> div classcol-md-6 text-center >h3 stylemargin-bottom: 0px; margin-top: 3px; font-weight: 400; color: #BF9865;>ASK THE DOCTOR!/h3>/div> div classcol-md-6>p stylecolor: #fff; font-size: 14px; line-height: 20px;>You can send your questions tobr>Prof.Dr. Kaan Aydos/p>/div> form idcontact1 methodpost> div classcol-md-6> div classform-group stylemargin-bottom: 10px;> input typetext classform-control namename idname placeholderName required> /div> /div> div classcol-md-6> div classform-group stylemargin-bottom: 10px;> input typeemail classform-control nameemail idemail placeholderEmail required> /div> /div> div classcol-md-12> div classform-group stylemargin-bottom: 10px;> textarea classform-control rows namemesaj idmesaj placeholderMessage required>/textarea> /div>input typehidden idsayfa namesayfa valuesoru> div classmessage styletext-align: center; color: #fff; font-weight: 400; margin-top: 0px; display: none;width: 100%;font-size: 15px;>/div> input classbtn btn-primary btn-play--hoverPrimary btn-block typesubmit idbutony valueSEND MESSAGE stylefont-size: 14px;> /div> /form> /div> div classfooter-xs-middle text-center> div classfooter-form-middle wow fadeIn data-wow-delay0.1s> img classimg-responsive u-MarginBottom20 src/assets/images/footer-logo-siyah.png altdrkaanaydos.com> p>info@drkaanaydos.com/p> div classtel>p>/p>/div> div classsocial-links sl-default gray-border-links border-link circle-link colored-hover u-MarginTop10> a hrefhttps://www.facebook.com/profdrkaanaydos classfacebook target_blank>i classfa fa-facebook>/i>/a> a hrefhttps://twitter.com/profdrkaanaydos classtwitter target_blank>i classfa fa-twitter>/i>/a> a hrefhttps://www.youtube.com/channel/UC5KhVnY42RNm-LBQNDC8Mpg classyoutube target_blank>i classfa fa-youtube>/i>/a> a hrefhttps://www.instagram.com/prf.dr.kaanaydos/ classinstagram target_blank>i classfa fa-instagram>/i>/a> /div> /div> /div> /div> /div> /div> div classbg-darker footer-form-bottom text-white u-BoxShadow40> div classcontainer> div classrow text-sm u-MarginTop20--> div classcol-md-6 text-left text-center--sm> p classu-LineHeight2>© 2025 Prof.Dr. Kaan Aydos - All rights reserved./p> /div> div classcol-md-6 text-right text-center--sm> div classtext-center--sm>a hrefhttp://bossgrey.com target_blank>img src/assets/images/boss-grey.svg height30 width30 altagency | bossgrey.com/>/a>/div> /div> /div> /div> /div> /div> /footer> !-- End Footer -->div idcontact classmfp-hide white-popup-block text-center> div classcontact-form text-center> h1 stylemargin-bottom: 15px; margin-top: 0px; font-weight: 700; letter-spacing: 0px;>ASK THE DOCTOR!/h1> p stylefont-size: 17px; margin-bottom: 25px; line-height: 22px; color: #fff;>You can send your questions tobr>b>Prof.Dr. Kaan Aydos/b>br>br>Mahatma Gandhi Caddesi, 19/7 06700 Cankaya, Ankara / TURKEYbr>+90 312 437 3121 +90 312 508 2258/p> form idcontact2 methodpost> div classform-group stylemargin-bottom: 10px;> input typetext namename idname classform-control form-control--white placeholderName requiredrequired> /div> div classform-group stylemargin-bottom: 10px;> input typeemail nameemail idemail classform-control form-control--white placeholderE-Mail requiredrequired> /div> div classform-group> textarea classform-control form-control--white rows namemesaj idmesaj placeholderMessage required stylemax-height: 130px;>/textarea> /div>input typehidden idsayfa namesayfa valueiletisim> div classmessages styletext-align: center; color: #000; font-weight: 400; margin-top: -5px; display: none;>/div> input classbtn btn-black btn-block u-MarginTop30 typesubmit idbutonx valueSEND stylefont-size: 14px;> /form> /div> /div>!-- Global site tag (gtag.js) - Google Analytics -->script async srchttps://www.googletagmanager.com/gtag/js?idUA-156275819-1>/script>script> window.dataLayer window.dataLayer || ; function gtag(){dataLayer.push(arguments);} gtag(js, new Date()); gtag(config, UA-156275819-1);/script> !-- inject:js --> script src/assets/js/plugins.js>/script> script src/assets/js/wow.min.js>/script> script src/assets/js/alien.min.js>/script> script src/assets/js/instagram-feed.js>/script> script src/assets/js/validator.min.js>/script> script src/assets/js/mailer.js>/script>/body>/html>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]